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Abstract: Breast milk is a natural food and important component of infant nutrition. Apart from
the alimentary substances, breast milk contains many important bioactive compounds, including
endogenous microRNA molecules (miRNAs). These regulatory molecules were identified in various
mammalian biological fluids and were shown to be mostly packed in exosomes. Recently, it was
revealed that plant food-derived miRNAs are stably present in human blood and regulate the
expression of specific human genes. Since then, the scientific community has focused its efforts on
contradicting or confirming this discovery. With the same intention, qRT-PCR experiments were
performed to evaluate the presence of five plant food-derived miRNAs (miR166a, miR156a, miR157a,
miR172a and miR168a) in breast milk (whole milk and exosomes) from healthy volunteers. In whole
milk samples, all examined miRNAs were identified, while only two of these miRNAs were confirmed
to be present in exosomes. The plant miRNA concentration in the samples ranged from 4 to 700 fM.
Complementary bioinformatics analysis suggests that the evaluated plant miRNAs may potentially
influence several crucial biological pathways in the infant organism.
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1. Introduction
Breast milk is perceived as required for optimal growth and development of the infant [1,2].
In addition to supplying the infant with vitamins and nutrients, numerous detailed studies have
shown that breast milk contains a wide range of other bioactive compounds that stimulate body
growth, brain development, shape the gut microbiota, participate in nutrient absorption, and play a
vital role in the appropriate adaptive and innate immune responses [1,3–5]. According to other reports,
breast milk may also decrease infantile mortality, as well as decrease the risk of obesity and type 2
diabetes [6–9]. The above-mentioned bioactive compounds are represented by minerals, hormones,
immune cells (e.g., leukocytes and macrophages), specific proteins (e.g., immunoglobulins, cytokines,
defensins, and lactoferrin), as well as microRNA molecules (miRNAs) [3,5,10–12].
miRNAs are a class of small (19–24 nt), single-stranded particles that mediate post-transcriptional
gene expression through target mRNA translation inhibition or degradation [13–15]. By these means,
miRNAs control crucial biological processes, such as metabolism, apoptosis, developmental timing,
cell proliferation, immune responses, hormone signaling, differentiation, and many others [16–19].
In addition to breast milk [11,20], miRNAs have been discovered in several other body fluids, such
as plasma, serum, saliva, urine, and tears [21–25]. Furthermore, it was shown that the profiles of
miRNAs, especially in the serum, plasma, and urine, are tightly correlated with various diseases and
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pathological states. This made these molecules suitable as new biomarkers for diagnosis, prognosis,
and monitoring patient treatment response [21,26–28].
Comparison between breast milk and blood miRNA profiles has suggested that milk miRNAs
may originate from the mammary epithelium and maternal circulation [29,30]. According to different
studies, milk miRNA profiles vary considerably and expectedly between individuals, probably
reflecting the mother’s background, e.g., race, age, health, and lifestyle [31,32]. Differences in milk
miRNA profiles were also observed between the different breast milk fractions (e.g., fat, cells, and skim
milk) during the lactation period, and even at different times of the day, which may be influenced by the
specific infant’s needs at different time points or developmental stages [20,30,32–34]. Moreover, recent
study has shown that the profile of milk miRNAs is also determined by the date of infant delivery [35].
Many researchers reported that membranous vesicles, named exosomes, that are present in breast milk,
are enriched in miRNAs [11,31,36–38]. Exosomes are shown to protect these molecules from harsh
conditions in the human gastrointestinal (GI) tract. Thus, several groups of scientists have assumed that
miRNAs may be transferred into these carriers to the bodies of infants via the GI tract, and are likely
to contribute to infant development, as well as protection against infections [11,31,37]. Additionally, it
was indicated that exosomal miRNAs play important roles in an infant’s metabolic “programming”
and growth [39–41]. The presence of bovine-derived miRNA molecules in various milk products
was also confirmed by a few groups [42–44]. Similar to the human molecules, the miRNAs from raw
bovine milk were shown to be packed in exosomes, which protect them from degradation [38,45–47].
Nevertheless, the homogenization, pasteurization, fermentation and other processing of milk alter the
bovine miRNA concentration [48–50]. Baier et al. propose that certain bovine milk-derived miRNAs
are bioavailable, and are present in adult human blood after consumption [51]. Moreover, one of these
miRNAs, miR-29, was shown to regulate specific human gene expression [51].
Intriguingly, the possibility of cross-kingdom gene expression regulation by miRNAs was shown in
the work of Zhang et al. in 2012 [52]. The authors reported that plant food-derived miRNAs are present
and stable in human blood. In addition, they provide evidence that one of the identified molecules,
namely rice MIR168a, can target the mRNA of the low-density lipoprotein receptor adaptor protein 1
(LDLRAP1), and thus reduce its expression level in the blood and liver of rice-fed mice [52]. This, in turn,
results in an increase of low-density lipoproteins (LDL) in animal plasma. Zhang et al. also showed that
most of the MIR168a present in the serum is packed in microvesicles (MV) [52]. Following the described
research, a great number of studies were published and contribute to the argument on whether plant
miRNAs can transfer to human circulation and, most of all, whether they are able to effectively regulate
gene expression in a cross-kingdom manner. The majority of these up-to-date reports (from both fronts)
were reviewed and discussed in the recently published article by Lukasik et al. [53] and Perge et al. [54].
Our group also took part in this debate that continues to the present day. In one of the studies carried
out by our group, in silico examination was performed to determine if potentially food-derived miRNA
molecules that enter the circulatory system can be found in exosomes isolated from mammalian breast
milk [55]. Using various computational approaches, an accurate bioinformatics analysis of publicly
available libraries generated from the high-throughput sequencing of human and porcine breast milk
miRNAs was performed. As a result, 35 and 17 plant miRNAs species were identified in human and
porcine exosome samples, respectively [55]. Molecules with the highest abundance level included
miR166a, miR951, miR156a, miR168a, and miR472. In the past year, Bagci et al. have questioned these
findings, concluding that the discovered plant miRNAs in mammalian milk samples were artifacts [56].
With inspiration from all the above-mentioned findings, an independent in vitro qRT-PCR
experiment supported with appropriate controls was performed and showed that the five evaluated
plant food-derived miRNAs were present in the human breast milk (whole milk and exosomes) of
healthy volunteers. To supplement these results, a bioinformatics analysis was carried out, which
proposed that the examined plant miRNAs, namely miR156a, miR167a, miR168a, miR172a, and
miR166a, may potentially influence several essential biological pathways in infants. The presented
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findings are consistent with previous reports by our group and reveal another intriguing potential of
plant miRNAs.
2. Results
2.1. RNA Quality and Concentration
The total RNA from whole human breast milk and exosome fractions was isolated using a
commercial kit (column-based method), which prevents the loss of small RNAs [57]. After procedure
modification (repetition of phenol-chloroform extraction step), good quality RNA was obtained for
all except two (R3 and R5 exosome fraction) of the samples (Table 1). Total RNA extracted from
the whole milk samples gave higher concentrations (from 94 to 1018 ng/µL) in comparison to the
RNA purified from the exosome fraction (from 21 to 228 ng/µL). The miRNAs were identified on the
electropherograms in all examined samples, with varying profiles among them. In the case of the RNA
samples extracted from whole milk, the miRNA concentration ranged from 13 to 51 ng/µL, and the
estimated percentage ratio of the miRNA to small RNA was approximately 40%. In turn, the miRNA
concentration in the RNA samples isolated from the exosomes was between 9 and 37 ng/µL, and the
estimated percentage ratio of miRNA to small RNA varied between samples, ranging 19–45%.
Table 1. RNA concentration obtained from whole milk and the exosomes fraction of the breast
milk samples. Concentration of total RNA was measured on a NanoDrop spectrophotometer.
The concentration of microRNA molecules (miRNAs) and the miRNA/small RNA ratio was
measured with the Agilent Bioanalyzer 2100 instrument. Isolation efficiency is presented as the
% of syn-cel-miR-39 recovered during the isolation procedure (calculated using data from qRT-PCR
analysis for syn-cel-miR-39 in each sample).








R1 1018 51.3 43 9
R2 120 20.35 43.5 18.5
R3 94 15.15 40 13.4
R4 407 41 40.5 11.9
R5 134 20.25 43 18.8
R6 111 13.7 45 14.4
Exosomes
R1 228 37.19 19.5 9.95
R2 40 18 33.5 17.8
R3 42 * 15.45 29.5 17.7
R4 143 15.35 27 13.9
R5 21 * 10.85 42.5 18.3
R6 23 9.75 45 27.15
* samples with A260/280 ratio < 1.8.
2.2. Plant miRNAs Are Detectable in Human Breast Milk via qRT-PCR
To experimentally verify whether plant miRNAs are present in human breast milk, five plant
miRNAs were selected, namely miR156a, miR172a, miR166a, miR167a, and miR168a. Synthetic
cel-miR-39 (intentionally added during isolation procedure) was used for the qRT-PCR technical
control and monitoring of the miRNA purification efficiency (Table 1). The 12 RNA samples (extracted
from whole milk and the corresponding exosomes fraction) coming from six healthy women were
subjected to qRT-PCR analysis using TaqMan® technology that is designed for and commonly used in
miRNA studies [34,44,58,59]. The absolute concentration of each miRNA was calculated according to
the standard curve generated using a synthetic plant miR172a at known concentrations (Figure S3a).
As shown in Figure 1, all the selected plant miRNAs were detected in whole milk samples. However,
not all the examined miRNAs were present in each evaluated sample. Whilst, miR168a, miR156a,
and miR166a were the most frequently found molecules, miR167a was detected in two samples, and
miR172a was only detected in one whole milk sample. Evaluation of the plant miRNA abundance in
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the RNA samples extracted from exosome fraction revealed only two out of the five plant miRNAs
chosen for the study. In addition, miR168a was identified in all six samples and miR156a in three
samples. As expected, most of the evaluated plant miRNAs were detected in quite low concentrations,
namely in the range of 4.3 to 8.5 fM. In every sample the control, synthetic cel-miR-39, was detected in
similar amounts (ranging between 1.4 and 4.3 pM; Figure 1-inserts) following similar added quantities.
Human hsa-miR-148a, one of the most highly expressed miRNAs in breast milk exosomes [11,60],
was additionally included as an endogenous control for the entire experimental procedure. As can
be seen in Figure 1 (inserts), hsa-miR-148a was detected in all samples, in a concentration range of
6.5–50 pM in whole milk samples and 1.2–12.5 pM in exosome fractions. The presented result shows
that adequate methodology has been employed throughout the whole experimental procedure.
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Figure 1. The absolute concentration of the examined plant miRNAs in human breast milk samples.
The five selected plant miRNAs were measured by qRT-PCR in human (a) whole breast milk and
(b) exosomes isolated from breast milk samples. Calculations were based on the standard curve
generated using the synthetic miR172a molecule. Endogenous hsa-miR-148a and synthetic cel-miR-39
served as controls (inserts). N = 6, error bars ± SD.
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The concentrations of miR168a, which were detected in all the examined whole milk and exosome
samples, were approximately 100 times higher (300–700 fM) than those of the rest of the examined plant
miRNAs. It should be mentioned that negative, no-template controls for reverse transcription and
real-time PCR were always performed for all the examined miRNAs (in each experiment), and no Cq
value for any of the samples was obtained. Further controls for miR168a were additionally performed.
To exclude non-specific signals from the isolation procedure (e.g., contamination connected with
reagents used), total RNA isolation was performed from 2 mL of nuclease-free deionized water, instead
of milk. The obtained “RNA sample” was used as a template for qRT-PCR. Moreover, real-time PCR
reaction with primers specific for miR168a and non-specific complementary DNA (cDNA) matrices
(obtained in reverse transcription using total RNA milk sample and stem-loop primers specific for
different miRNAs, such as miR172a or syn-cel-miR-39) were also performed. In all the above-described
controls, miR168a was not detected.
2.3. Relative qRT-PCR
Exogenous spike-in RNA, such as synthetic Caenorhabditis elegans miRNA (cel-miR), can be used
not only for monitoring the efficiency of miRNA purification and reverse transcription, but also as a
normalization control [29,31,42,58]. A stable reference control is obtained by adding the same amount
of spike-in miRNA after the lysis step to the same volume of each examined sample. To date, there is
no well-established endogenous control for milk sample normalization, which is mostly due to high
expression differences between different lactation stages and fluctuations in the miRNA profile during
the day [61]. Hence, to compare the expression levels of miRNAs among the different milk samples,
the Cq value of the synthetic cel-miR-39 was used. Data obtained for the whole and exosome fractions
of milk are presented separately in Figure 2. The relative level of the detected plant miRNAs was
similarly low in all the tested milk samples. As expected, the level of endogenous human hsa-miR-148a
was five orders of magnitude greater than the level of plant miRNAs. In accordance with the values
presented in the absolute miRNA content analyses, the relative level of miR168a was greater than that
of the other plant miRNAs (2 orders of magnitude).
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Figure 2. Relative plant miRNAs levels in human breast milk samples. The five selected miRNAs
were measured by qRT-PCR in human (a) whole breast milk and (b) exosomes isolated from milk
samples. Calculations were based on normalization to the spike-in synthetic cel-miR-39. The y-axes
show arbitrary units representing the relative miRNA expression levels. N = 6, error bars ± SD.
Int. J. Mol. Sci. 2018, 19, 37 6 of 17
Taking into consideration the fact that breast milk samples were collected from mothers that
have varied dietary preferences (vegetarian or non-vegetarian), the evaluation of the differences in
the identified plant miRNAs levels between these two groups was performed (Figure 3). There was
no statistically significant difference between the plant miRNAs levels in the exosome samples or the
whole milk samples obtained from vegetarian and non-vegetarian mothers. In both groups, the plant
miRNAs were detected in a similar concentration range. The only two exceptions were observed in
the whole milk samples, where miR172a was identified in one sample (R5) from a non-vegetarian
mother, and the level of miR168a was statistically significantly lower in vegetarian volunteers than
non-vegetarian ones.
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Figure 3. Comparison of the plant miRNAs levels measured in breast milk samples from the vegetarian
and non-vegetarian volunteers. The five selected miRNAs were measured by qRT-PCR in (a) whole
breast milk and (b) xosomes isolat d from breast milk samples collected from vegetarian and
non-veg tarian volunteers. The y-axes how arbitrary units representing the relative quantification of
the plant miRNAs levels. N = 6, unpaired T-t t, error bars ± SD, * p-value < 0.05.
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2.4. In silico Evaluation of the Identified Plant miRNAs Influence on the Infant
The selection and annotation of the miRNA targets are the first steps to determine the potential
role of miRNAs in the cell or organism. As initial targets, the 3′ UTR, 5′ UTR and coding sequences
representing ~20,100 unique human genes were collected. Target prediction with the use of the
tools4miRs service suggested 271 unique targets for miR156a, 88 unique targets for miR166a, 4 unique
targets for miR168a, 15 unique targets for miR167a and 7 unique targets for miR172a (Table S1).
Most of the plant miRNAs binding sites were in coding sequence regions, then in 3′ UTRs and 5′
UTRs. Functional annotation was carried out, namely, Kyoto Encyclopedia of Genes and Genomes
(KEGG) pathway mapping, and showed that the proposed targets are mostly involved in, inter alia:
purine metabolism (ko00230; e.g., XDH and PDE1C), RNA transport (ko03013; e.g., NUP85 and
XPO5), thyroid hormone signalling (ko04919; e.g., PLCG1), hippo signalling (ko04390; e.g., PPP2R2),
calcium signalling (ko04020; e.g., SLC8A1), Th1 and Th2 cell differentiation (ko04685; e.g., NFATC3
and STAT1), and chemokine signaling pathways (ko04062; e.g., CXCR2). The full KEGG pathway
mapping results are presented in the Table S2. The performed Gene Ontology (GO) term annotations
from the “Biological Process” category additionally revealed that the predicted plant miRNAs interact
with targets playing various, important roles such as protein transport (GO:0015031; e.g., RINT1),
regulation of transcription from the RNA polymerase II promoter (GO:0006357; e.g., MED22 and
MED24), involvement in immune system processes (GO:0002376; e.g., LAIR1), protein phosphorylation
(GO:0006468; e.g., CDC42BPA), signal transduction (GO:0007165; e.g., NSMAF), nervous system
development (GO:0007399; e.g., NOTCH2 and ARHGAP26), and involvement in apoptotic processes
(GO:0006915; e.g., PDCD6). The graph and table presenting the full GO annotations received for
373 targets can be found in Figure S1 and Table S3, respectively. To better recognize the influence of
plant miRNAs on infants, statistical GO enrichment analysis was performed, which indicated few
significant GO terms functionally describing the predicted human targets: regulation of localization
(GO:0032879), regulation of small GTPase mediated signal transduction (GO:0051056), Ras protein
signal transduction (GO:0007265), Rac guanyl-nucleotide exchange factor activity (GO:0030676), and
enzyme binding (GO: 0019899). Detailed GO enrichment results can be found in a graph form in
Figure S2.
3. Discussion
An extensive number of studies has shown that breast milk is the gold standard of infant
nutrition, and is composed of different bioactive compounds that contribute to early infant
development [1–3,5,10]. One of these compounds are miRNA molecules [11]. These molecules have
been intensively investigated since their discovery in 1993 [62,63]. However, miRNAs, and especially
plant miRNAs, gained even more attention after a report describing their ability to regulate gene
expression in a cross-kingdom manner. Zhang et al. first provided evidence that food-derived
miRNAs stably transfer to the human blood and inhibit the expression of specific human gene [52].
Since Zhang et al.’s discovery, many scientists have focused their efforts on answering some intriguing
questions, such as whether cross-kingdom gene expression regulation by plant miRNAs is possible
and biologically meaningful. Some of them have successfully confirmed this phenomenon, and have
perceived it as an opportunity for novel therapeutic approaches. Others, in turn, are convinced that
the mentioned phenomenon is the result of false positive effects, and provide several supporting
pieces of evidence for their hypothesis [53]. Aside from the important questions that were raised,
there are several others that need to be answered, such as how plant miRNA molecules enter the
targets animal cells. One of the possibilities is that they are packed into intracellular carriers, such
as exosomes. Endogenously originating miRNAs are highly enriched in exosomes isolated from
different body fluids, including breast milk [25,31,36]. Vesicles were shown to protect miRNAs from
degradation by RNases. In one of the studies carried out by our group, the publicly available data
from the high-throughput sequencing of miRNAs isolated from mammalian breast milk exosomes
were analyzed [55]. This in silico study revealed that several plant food-derived miRNAs were present
Int. J. Mol. Sci. 2018, 19, 37 8 of 17
in the analyzed samples and may potentially influence important biological pathways in infants.
These positive results, similar to others in the field, were questioned as to whether they showed the
effect of contamination and artifacts, rather than real food-derived miRNAs [56]. In the presented study,
the independent qRT-PCR experiments were performed to evaluate the abundance of the selected
plant miRNAs in human breast milk collected from healthy volunteers. Five plant miRNAs, namely
miR168a, miR156a, miR166a, miR172a, and miR167a, were chosen for investigation for three reasons:
(1) their presence in mammalian breast milk exosomes revealed by Lukasik et al. [55]; (2) their level of
abundance in animal blood/plasma discovered by, e.g., Zhang et al. [52]; and (3) the presence of these
miRNAs in plants eaten by volunteers up to 24 h before breast milk sample collection.
Detection of small amounts of miRNAs in serum, plasma or milk samples requires a method with
high sensitivity and specificity. This is especially important in studying exogenous miRNAs, such as
plant miRNAs, which are believed to be acquired orally through food intake, a hypothesis that has
raised a great deal of controversy. Therefore, the qRT-PCR method with the TaqMan® technology was
chosen, which ensures high specificity and a lack of false positive results. The detection level of the
miRNA molecules may depend also significantly on the real-time PCR instrument used; therefore, it
was verified by generating a parallel standard curve on two instruments, LightCycler 480 (Roche, Basel,
Switzerland) and Mic (Bio Molecular Systems, Upper Coomera, Queensland, Australia). As can be
seen in Figure S3, the Mic real-time cycler detected lower standard concentrations than the LightCycler
480, and therefore all the experiments in this study were performed using this instrument. The use of
the Mic real-time cycler enables the detection of plant miRNAs present in low amounts in the examined
samples, which could not be possible with the use of the LightCycler 480. All the plant miRNAs chosen
for this study were detected in the examined milk samples. There were some differences between the
samples as not all the chosen plant miRNAs were present in every sample. In the whole milk samples
all the chosen plant miRNAs were detected, while in the samples obtained from the exosome fraction,
only miR156a and miR168a were present. As expected, the concentrations of the plant miRNAs
were lower than those of the endogenous hsa-miR-148a control, and were in the range of 4.3–8.5 fM.
However, for one plant miRNA, namely miR168a, a higher concentration in all the examined samples
was detected (up to 700 fM). As many experimental controls were performed, such as the use of 2 mL
of water instead of milk for RNA isolation and no-template controls in the RT and qPCRs reactions,
contamination, as well as a false-positive result, can be excluded. Efficiency of the miRNAs isolation
was in the range of 9–27%, and potentially depended on the sample composition, as the same isolation
procedure dedicated for small RNAs was used for all the examined samples. Therefore, it could be
inferred that the detected levels of miRNAs are underestimations of the true levels. This may also
be a potential explanation why only two plant miRNAs were identified in the exosomes, namely, the
isolated miRNA fraction was insufficient to reach the qRT-PCR signal. Additionally, there may be a
specific selection mechanism that packs certain miRNAs in the mentioned carriers. These results also
indicate an important issue, namely that the false negative effect should be taken into consideration in
this type of research (with low concentrations of miRNAs) to avoid further improper conclusions.
Breast milk samples were collected from mothers with varied dietary preferences, specifically,
from vegetarians and non-vegetarians. In this manner, it was interesting to evaluate any potential
differences in the plant miRNAs patterns between these two groups of volunteers. As shown in the
results section and in Figure 3, there was no difference in the miRNAs concentrations in the exosome
samples. In the case of the whole milk samples, only the levels of miR172a and miR168a were higher
in the non-vegetarian samples than in the vegetarian samples. Additionally, PCA analysis was also
performed and it was confirmed that there were no significant similarities in the plant miRNA profiles
within the analyzed groups, since samples representing vegetarians and non-vegetarians did not
cluster together (Figure S4). One could expect that, regarding the dietary preferences, the breast milk
samples collected from the vegetarian mothers should have higher concentrations of plant miRNAs.
However, it must be noticed that although three of women participating in the study were vegetarians,
all of them ate a variety of plants every day. This could potentially explain the lack of difference
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between these groups. Another possibility is that non-vegetarian mothers ate more plant food in the
time before breast milk sample collection, or that the analyzed number of samples is simply too small
to indicate any statistically significant difference in the levels of the identified plant miRNAs.
As mentioned at the beginning of this discussion, breast milk is necessary for appropriate
growth and development of the infant. The results of several studies have also suggested that the
infant diet, especially a breastfeeding pattern with frequent consumption of fruits and vegetables, is
positively associated with higher IQ in later years, improved cognitive development, and a lower
risk of adiposity [64–66]. The described outcome may be a summary effect of the actions of various
bioactive compounds present in breast milk, vegetables, and fruits, including plant miRNAs. Thus,
to propose the potential influence of the five identified plant miRNAs on infants, miRNA target
prediction and functional annotations were performed. The human targets selected by three out of five
independent bioinformatics methods were further considered. This type of consensus prediction is
widely used to reduce the number of false positive results [67,68]. For the five analyzed plant miRNAs,
385 unique putative human targets were proposed (Table S1). Among them, targets encoding proteins
involved in regulation of localization, enzyme binding, Ras protein signal transduction and Rac
guanyl-nucleotide exchange factor activity were significantly enriched (Figure S2). The Ras and Rac
proteins are small GTPases belonging to the Ras superfamily that control various essential biochemical
processes in a cell, such as cell proliferation and differentiation, survival, apoptosis, cytoskeleton
organization, vesicular transport, protein sorting, and others. Ras molecules act as molecular
switches, changing between an active (GTP-bound) and an inactive (GDP-bound) conformational state.
Endogenous miRNAs identified in the animals’ breast milk exosomes are shown to affect immunity,
inter alia. It was also proposed that the plant miRNAs analyzed in this study potentially influence the
inflammatory responses and immune system. One of the predicted targets was the mRNA sequence
of leukocyte-associated immunoglobulin-like receptor-1 (LAIR1) that is expressed by most immune
cells. Cross-linking of this protein inhibits Natural Killer (NK) cell and T cell-mediated toxicity, as
well as B cell-mediated signaling [69,70]. Another important immune-related proposed target is the
CXC chemokine receptor type 2 (CXCR2) which is a key regulator of neutrophil recruitment and
effector responses in a site of inflammation [71]. From the point of view of the infant health, targets
encoding molecules involved in transport, signaling pathways, regulation of transcription, neuron
development, apoptosis and metabolism are also essential (Table S2 and Figure S1). As mentioned in
the Introduction, human miRNAs abundant in breast milk participate in various important biological
processes including immune system development, cell differentiation, endo/exocytosis, metabolic
processes, growth, and apoptosis [20,72]. In this manner, identified plant miRNAs may have synergistic
or antagonistic roles in relation to these molecules, which altogether potentially result in a complex
regulator system. Doubts have been immediately raised in regards to this type of analysis, and to its
results concerning whether the identified plant miRNAs are in biologically active amounts that will
enable them to effectively regulate the presented human targets. It was estimated that approximately
100–1000 copies of miRNA per cell should sufficiently affect gene expression [73,74]. However, it
should be noted that the mechanism of gene expression regulation by endogenous miRNAs has
been intensively investigated during the past years, and still new reports are appearing showing
how target levels, their half-lives, processing, complementary, competing endogenous molecules,
and other conditions affect the miRNAs effectiveness. Thus, it is very difficult to certainly state
that a given amount of plant food-derived miRNA is sufficient or insufficient to influence human
biological processes, especially when we recall that not all plant miRNAs present in food sources are
able to pass through the GI tract and enter human circulation [52]. This phenomenon still needs to be
deeply investigated.
To summarize, the present study confirms our earlier findings and shows that certain plant
miRNAs are present in human breast milk, including exosome fractions. The concentrations of the
identified molecules were rather low compared to the endogenous control, and varied significantly
between the samples, which may reflect inter-individual properties. Additionally, no specific
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association was observed between the dietary pattern of the mothers from which the breast milk
was collected and the profiles of the evaluated plant miRNAs. To avoid any further speculation, the
appropriate controls were performed at different stages of the experiment and confirmed that the
obtained results do not represent a false-positive effect. The potential functionality of the identified
plant miRNAs was evaluated by bioinformatics analysis, which showed that the mentioned molecules
may influence important biological processes in infants. Considering all the above-discussed results,
the present study revealed novel properties of plant food-derived miRNAs, which may potentially be
used further in developing natural medical solutions for treating known diseases in very small babies.
4. Materials and Methods
4.1. Ethics Statement
All the experiments were approved by the Local Bioethics Committee supervising the Medical
University of Warsaw (KB/71/2016; 15 March 2016) and performed in compliance with the Declaration
of Helsinki. Written informed consent was obtained from all the mothers prior to the study. All mothers
were also asked to fill out a questionnaire concerning age, lactation stage, any diagnosed diseases,
medications used, and their daily dietary pattern (e.g., vegetarian or non-vegetarian, but including
plant food every day). Mothers were also asked to list all the plant food that they consumed up to 24 h
before the milk sample collection (Table 2).
Table 2. Information regarding participant age, lactation stage, dietary pattern and plant food
consumed up to 24 h before milk sample collection. All presented information was collected from the
questionnaire obtained from the mothers after they signed informed consent.
Mothers’ ID R6 R1 R2 R4 R5 R3




1.5 3.5 7 2.5 5 8


















































4.2. Milk Sample Collection
Human mature milk samples were aseptically collected from six mothers using an electric or
manual breast pump, sterile bottles, and other accessories. All participating women and their infants
were healthy at the time of milk collection. Mothers also did not take any medication/supplements
at that time, and did not use any cosmetics/solutions/wraps for breasts up 24 h before sample
collection. Depending on the sample volume (range, 25–65 mL), the milk was separated into 5 mL
aliquots, directly transported to the laboratory on dry ice, and stored at −80 ◦C until further analysis.
The collected milk samples differed in color (from very white to distinctly yellow) and in the lipid
content, which was visible after centrifugation during the exosome isolation procedure.
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4.3. Total RNA Extraction from Whole Milk and Exosome Fraction
Total RNA extraction was performed using a mirVana isolation kit (Ambion) with some
modifications. After thawing the milk on ice, 2 mL of whole milk was diluted with 4 mL of
Lysis/Binding solution. To ensure effective denaturation, the samples were well mixed by vortexing,
and incubated for 5 min at room temperature. After lysis, 1.6 fmol syn-cel-miR-39 (synthetic miRNA
from C. elegans, Qiagen N.V., Hilden, Germany) was added to each sample as a spike-in control. Next,
1/10 volumes of miRNA homogenate additive were added, mixed by vortexing for 30 s, and incubated
on ice for 10 min. Then, an equal volume of acid/phenol/chloroform solution was added, mixed by
vortexing for 1 min and centrifuged at 10,000× g for 20 min. After collecting the aqueous phase, the
extraction step with acid/phenol/chloroform solution was repeated. Subsequent steps were processed
according to the manufacturer’s protocol. At the end of the procedure, RNA was eluted in 100 µL of
nuclease-free deionized water (EurX, Gdansk, Poland).
To isolate the total RNA from the exosome fraction, 3 mL of whole milk sample was centrifuged
at 2000× g for 10 min to remove the fat globules. The supernatant was centrifuged further at 12,000× g
for 30 min and filtered through a 0.22 µm MF-Millipore MCE membrane filter (Millipore, MA,
USA) to eliminate the cells and cellular debris. Two mL of supernatant was mixed with 500 µL
of the ExoQuick Exosome Precipitation Solution (SBI, Palo Alto, CA, USA) and incubated at 4 ◦C
for 12 h. The ExoQuick/supernatant mixture was centrifuged at 1500× g for 30 min to obtain a
beige exosome pellet. The RNA isolation from the exosome fraction was performed immediately
by adding 1.2 mL of Lysis/Binding solution. After lysis, which occurred during pipetting, 1.6 fmol
syn-cel-miR-39 was added to each sample as a spike-in control. Further isolation steps were performed
according to the mirVana isolation kit manufacturer’s protocol, with repeated extraction steps
with acid/phenol/chloroform solution. The concentration of the syn-cel-miR-39 recovered in both
procedures was used for the calculations of the miRNA isolation efficiency in each sample.
4.4. RNA Analysis and Quantifications
The RNA concentration and purity (A260/280 ratio) were measured using the NanoDrop
spectrophotometer (ND-1000, Thermo Scientific, Waltham, MA, USA). The miRNA concentration
and miRNA/small RNA ratio were quantified by micro-capillary electrophoresis using the small
RNA Chip kit (Agilent, Santa Clara, CA, USA) with the Agilent Bioanalyzer 2100 instrument (Agilent,
Santa Clara, CA, USA).
4.5. Reverse Transcription
Reverse transcription reactions were performed using the TaqMan® miRNA reverse transcription
kit (Applied Biosystems, Foster City, CA, USA) with TaqMan® specific stem-loop primers (miR168a,
assay ID 007594_mat; miR156a, assay ID 000333; miR166a, assay ID 000347; miR172a, assay ID 000359;
miR167a, assay ID 000348; hsa-miR-148a-3p, assay ID 000470; cel-miR-39, assay ID 000200; Applied
Biosystems) in a volume of 15 µL according to the manufacturer’s protocol. In each reaction, 1 µL of
total RNA was used. RT was carried out in a thermal cycler (Labcycler SensoQuest, Syngen, Germany)
with the following programme: 16 ◦C for 30 min, 42 ◦C for 30 min, and 85 ◦C for 5 min, and held at
4 ◦C. RT products were stored at −20 ◦C prior to real-time PCR.
A standard curve was generated using chemically synthesized miR172a molecule (42.2 µM,
sequence: AGAAUCUUGAUGAUGCUGCAU), that was serially diluted (in range of 82–0.005 pM)
and added to the RT reaction mixtures at a volume of 1 µL per reaction.
4.6. Quantitative PCR Analysis
The qRT-PCR reactions were performed with TaqMan® Universal PCR Master Mix (no AmpErase®
UNG kit; Applied Biosystems), specific miRNA primers and hydrolysis probes (probe identifiers as
above, Applied Biosystems). Each reaction was scaled down to a total volume of 10 µL containing
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0.67 µL of RT product and was performed in triplicate. In each run of qRT-PCR, no-template controls
were performed. The qRT-PCR reactions were carried out using the Mic thermocycler (Bio Molecular
Systems, Queensland, Australia) at the following conditions: 95 ◦C for 2 min, followed by 40 cycles of
95 ◦C for 15 s and 60 ◦C for 1 min. The raw data was analyzed using the automatic quantification cycle
setting (Cq) for assigning the baseline and detection threshold.
Absolute concentrations of the miRNAs were calculated based on the standard curve obtained
from serial dilutions of synthetic miR172a reverse transcribed and amplified in real-time reaction.
The detection limit of the miRNA assay was designated as the highest Cq value (35.2) within the
linear range of the generated standard curve (Figure S3). Results with a Cq value >35.5 were excluded
from further analysis. The Cq value of the syn-cel-miR-39 was used to normalize the quantity of
plant miRNAs in each sample and to compare the expression levels between the milk samples (Delta
Ct method).
4.7. Prediction and Annotation of Putative Human Target Genes for Identified Plant miRNAs
To propose the potential influence of the identified food-derived molecules on the infants, the
putative human targets for the 5 plant miRNAs were predicted and annotated. In the first step of this
analysis, all available human 3′ UTR, 5′ UTR and coding sequences (CDS) were collected from the
Ensembl Genes database (December 2016, 87 release). Currently, there is no “golden standard” for plant
miRNA target prediction in a cross-kingdom manner, therefore target prediction was performed using
the tools4miRs meta-server (www.tools4mirs.org) [75], with 5 different target prediction algorithms
incorporated into the analysis: miRanda, PITA, Rna22, GUUGle and miRmap. Moreover, for each
programme, restrictive parameters were set up, specifically: (1) for Rna22: no G:U wobbles were
allowed in the “seed” region, −19 Kcal/mol was the maximum folding energy of the heteroduplex;
sensitivity was 63%, specificity was 61%, no mismatches were allowed in the “seed” region, 12 was
the minimum number of paired-up bases in the heteroduplex, 7 was the length of the “seed” region;
(2) for miRmap: 6 or 7 was the length of the “seed” region, no mismatches were allowed in the “seed”
region and no G:U wobbles were allowed in the “seed” region; (3) for miRanda: 160 was the minimum
score, and −19 Kcal/mol was the maximum folding energy of the duplex structure; (4) for PITA: −19
was the maximum ∆∆G score; and (5) for GUUGle: 12 was the minimum number of matches in the
duplex. From the results generated by tools4miRs, the unique target:miRNA pairs were collected if
the same exact miRNA binding site was predicted by at least 3 out of the 5 prediction algorithms.
For further annotation analyses, the Associated Gene Names and protein sequences encoded by the
gathered human mRNA targets were collected and used. The GO annotation was performed using
Blast2GO software (www.blast2go.com), in which the GO terms were obtained as a result of three
steps: (1) Blastp search against the “nr” NCBI database with the “mammals” taxon restriction and
E-value threshold of 1e−10, (2) mapping Blast hits on the GO terms and (3) filtering the annotations
with an E-value threshold of 1e−10. For the KEGG pathway mapping, the online service KAAS (KEGG
Automatic Annotation Server; http://www.genome.jp/tools/kaas/) [76] was used, which performed
Blastn comparison against the manually validated set of human genes in the KEGG GENES database.
The GO enrichment was done with the use of the Ontologizer program [77] and the predicted miRNA
targets served as a study set. In turn, all the available human sequences collected from the Ensemble
Gene database served as the population set. The “Term-For-Term” algorithm with Benjamini-Hochberg
correction for multiple testing and a p-value threshold set at 0.05 was chosen for the calculations.
4.8. Statistical Analysis
Data shown are presented as the mean ± SD of the quantitative PCR reaction triplicates.
The principal component analysis (PCA) was done with the use of the “stats” package in R, and
the calculations were based on the relative quantification data obtained for each of the 5 identified
plant miRNAs in whole breast milk samples. The comparison of the relative quantification
levels calculated for the 5 plant miRNAs identified in the whole milk and exosome samples from
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vegetarians/non-vegetarians was performed using the unpaired t-test. Differences were considered
statistically significant at a p-value < 0.05.
Supplementary Materials: Supplementary materials can be found at www.mdpi.com/1422-0067/19/1/37/s1.
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